相关实验视频

Updated: Jun 5, 2025

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

rs1799884 葡萄酶基因多态度调节对艾滋病毒状况和CD4细胞计数和病毒载荷的敏感性,在艾滋病进展者治疗前后进行治疗

Soufiane Hilmi^1,2, Ahd Ouladlahsen³, Bouchaib Bencharki²

¹Virology Unit, Viral Hepatitis Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.

AIDS research and human retroviruses

|December 11, 2024

概括

葡萄糖酶基因 (GCK) 中的rs1799884-C/T变异与艾滋病毒易感性和艾滋病进展有关. 某些基因型会增加感染风险,而另一些则提供保护,影响治疗反应.

科学领域:

遗传学遗传学是一种遗传学.
免疫学免疫学免疫学
病毒学病毒学

背景情况:

人类免疫缺陷病毒 (HIV) 导致艾滋病,这是一个重大的全球健康问题.
抗逆转录病毒疗法改善了艾滋病毒感染者 (PLHIV) 的治疗结果,但代谢综合征仍然是一个挑战.
葡萄糖酶基因 (GCK) 与代谢综合征有关,但其在艾滋病毒感染中的作用尚未被探索.

研究的目的:

调查GCK基因中的rs1799884多态和摩洛哥人口的艾滋病毒状况之间的关联.
为了确定这种GCK变种是否会影响对艾滋病毒感染的易感性,艾滋病的进展或治疗反应.

主要方法:

一项涉及207名艾滋病毒感染者 (PLHIV) 和181名未感染艾滋病毒的对照者的病例控制研究.
使用TaqMan试验对GCK rs1799884多态的基因型定型.
统计分析用于比较基因型分布,评估风险 (赔率) 和保护.

主要成果:

CT基因型显示HIV感染风险增加了4.47倍 (p=0.001).
在一个衰退模型 (OR=0.50,p=0.021) 中,TT基因型赋予了对HIV的保护.
在艾滋病病例中,CT基因型风险更高 (OR=9.37,p=0.0001),在主导模式下,CT/TT基因型增加了感染风险 (OR=7.67,p<0.0001).

结论:

GCK rs1799884-C/T变种可能会影响对艾滋病毒感染的易感性和艾滋病的进展.
这种GCK变种也可能影响PLHIV治疗的病毒载荷反应.
需要进一步的研究,以阐明将GCK变异与艾滋病毒病原性联系在一起的确切机制.

关键词:

艾滋病的进展艾滋病的进展 GCK GCK 在线观看艾滋病病毒艾滋病病毒艾滋病病毒 rs1799884 多形态的多态化易受感染的易感性.治疗对治疗的反应反应.

更多相关视频

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...